Poly Medicure Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2018
January 25, 2019 at 07:34 am EST
Share
Poly Medicure Limited announced unaudited standalone earnings results for the third quarter and nine months ended December 31, 2018. For the quarter, the company reported revenue from operations of INR 1,487.025 million against INR 1,257.469 million a year ago. Total income was INR 1,524.501 million against INR 1,292.937 million a year ago. Profit from operations before exceptional items was INR 263.141 million against INR 242.840 million a year ago. Profit for the period was INR 168.326 million against INR 165.356 million a year ago. Basic earnings per share (not annualized) were INR 1.91 against INR 1.89 per share a year ago.
For the nine months, the company reported revenue from operations of INR 4,268.206 million against INR 3,693.371 million a year ago. Total income was INR 4,380.069 million against INR 3,790.473 million a year ago. Profit from operations before exceptional items was INR 714.977 million against INR 698.258 million a year ago. Profit for the period was INR 448.008 million against INR 471.426 million a year ago. Basic earnings per share (not annualized) were INR 5.08 against INR 5.36 per share a year ago.
Poly Medicure Limited is an India-based medical devices company. The Company is engaged in manufacturing and selling medical devices. The Company holds a portfolio of over 375 patents covering a range of products in various areas, including vascular access, renal care, transfusion and diagnostics systems. These products cater to a range of therapeutic segments, such as infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. It supplies its products to more than 100 countries across Europe, Africa, the Americas, Australia, and Asia. Its products include IV cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others. It operates ten manufacturing facilities across India, China, Egypt and Italy.
POLY MEDICURE LIMITED 
